Core Viewpoint - The article highlights the recognition of Delisi Group's Chairman Zheng Simin for his contributions to quality transformation and high-quality industrial development, receiving the Shandong Provincial Governor's Quality Award, the highest quality honor established by the Shandong government [1][2]. Group 1: Award Recognition - Delisi Group's Chairman Zheng Simin received the Provincial Governor's Quality Award for his significant contributions to quality transformation and leading high-quality industrial development [1]. - The award is a biennial recognition of the quality governance capabilities and innovative practices of the awarded entities [1]. Group 2: Quality Management Practices - Delisi Group has established a comprehensive traceable system covering the entire industry chain from "feed breeding - ecological farming - scientific slaughter - deep processing - cold chain logistics - terminal services" [1]. - The company has obtained multiple international certifications, including ISO9001 and HACCP, and has set internal control standards that exceed national standards, ensuring food safety [1]. Group 3: Future Plans and Commitments - Delisi Group plans to leverage the award to deepen quality control across the supply chain and establish a quality firewall throughout the entire chain [2]. - The company aims to lead the formulation of national and industry standards for meat products and ready-to-eat dishes, establishing "Delisi Standards" as synonymous with high quality [2]. - Delisi Group will increase R&D investment through recognized national technology centers to promote the transformation of quality technology achievements [2]. - The company is committed to enhancing brand building and integrating into the "Good Products Shandong" initiative to showcase the quality strength of "Shandong Manufacturing" globally [2]. - Delisi Group emphasizes the importance of quality as a core competitive advantage and a social responsibility, with plans to deepen its main business and actively fulfill social responsibilities [2].

Core Viewpoint - The company emphasizes that quality is the foundation of pharmaceutical enterprises and is focusing on enhancing quality management to drive transformation and upgrade in the context of high-quality development in the pharmaceutical industry [1][5]. Group 1: Quality Management Initiatives - The company is committed to building a comprehensive quality control system that covers the entire supply chain, from raw material procurement to production and product delivery [2]. - A special audit team has been established to conduct in-depth on-site audits of key raw material suppliers across 13 provinces, ensuring stringent quality checks at critical stages [2][3]. - The company has set up a drug safety monitoring department to proactively track and manage product quality issues, transitioning from passive responses to active prevention [3]. Group 2: Compliance and Certifications - The company has successfully passed multiple certifications, including BRC and ISO22000, and its raw material products are exported to over 100 countries and regions [4]. - In the first eight months of the year, the raw material production facility hosted 63 audits from domestic and international clients, achieving a 100% pass rate [4]. Group 3: Cultural and Systematic Quality Focus - The company is fostering a culture of quality among all employees, emphasizing that quality awareness and professional capability are core competitive advantages in quality control [5][6]. - A "simulated flight inspection" mechanism has been established to conduct regular, comprehensive evaluations of production lines, identifying system vulnerabilities and optimizing management processes [6]. - The company aims to enhance its product quality management level and expand both domestic and international markets, laying a solid foundation for its transformation into a biotechnology enterprise [6].